Physician profile
Aloka Amarakone
NPI 1407051329
$1,918.76
in general payments reported to CMS, 2019-2025
33 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,654 · 2020: $215 · 2021: $50.09.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $238.37 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $198.84 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $188.66 | 2019-2020 | |
| Emd Serono, INC. | $112.43 | 2019 | |
| Lundbeck LLC | $110.15 | 2019-2021 | |
| Biogen, INC. | $87.71 | 2019 | |
| Csl Behring | $79.97 | 2019 | |
| Ge Healthcare | $75.25 | 2019-2020 | |
| Genzyme Corporation | $71.38 | 2019 | |
| Ucb, INC. | $64.10 | 2019 | |
| Abbvie INC. | $53.61 | 2020-2021 | |
| Amgen INC. | $49.75 | 2019 | |
| Amneal Pharmaceuticals LLC | $46.83 | 2019 | |
| Sunovion Pharmaceuticals INC. | $43.66 | 2019 | |
| Lilly USA, LLC | $42.30 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $41.46 | 2019-2020 | |
| Akcea Therapeutics, INC. | $40.97 | 2019 | |
| Alexion Pharmaceuticals, INC. | $38.55 | 2019 | |
| Acadia Pharmaceuticals INC | $35.97 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $32.14 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $30.74 | 2019 | |
| Neurocrine Biosciences, INC. | $26.74 | 2019 | |
| Adamas Pharmaceuticals, INC. | $25.50 | 2019-2020 | |
| Promius Pharma LLC | $25.09 | 2019 | |
| Avanir Pharmaceuticals, INC. | $24.46 | 2019 | |
| Zyla Life Sciences, INC. | $23.06 | 2019-2020 | |
| Vanda Pharmaceuticals INC. | $21.90 | 2020 | |
| Eisai INC. | $20.48 | 2019 | |
| Alnylam Pharmaceuticals INC. | $16.28 | 2019 | |
| Bausch Health US, LLC | $14.34 | 2019 | |
| Pfizer INC. | $13.93 | 2019 | |
| Braemar Manufacturing, LLC | $13.16 | 2019 | |
| Aquestive Therapeutics, INC. | $10.98 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aloka Amarakone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.